614 related articles for article (PubMed ID: 7756983)
21. Crystallographic structure of human gamma-thrombin.
Rydel TJ; Yin M; Padmanabhan KP; Blankenship DT; Cardin AD; Correa PE; Fenton JW; Tulinsky A
J Biol Chem; 1994 Sep; 269(35):22000-6. PubMed ID: 8071320
[TBL] [Abstract][Full Text] [Related]
22. Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen A alpha: geometry of the catalytic triad and interactions of the P1', P2', and P3' substrate residues.
Martin PD; Malkowski MG; DiMaio J; Konishi Y; Ni F; Edwards BF
Biochemistry; 1996 Oct; 35(40):13030-9. PubMed ID: 8855938
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin.
Ofosu FA; Fenton JW; Maraganore J; Blajchman MA; Yang X; Smith L; Anvari N; Buchanan MR; Hirsh J
Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):893-7. PubMed ID: 1590777
[TBL] [Abstract][Full Text] [Related]
24. The co-crystal structure of unliganded bovine alpha-thrombin and prethrombin-2: movement of the Tyr-Pro-Pro-Trp segment and active site residues upon ligand binding.
Malkowski MG; Martin PD; Guzik JC; Edwards BF
Protein Sci; 1997 Jul; 6(7):1438-48. PubMed ID: 9232645
[TBL] [Abstract][Full Text] [Related]
25. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ
Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168
[TBL] [Abstract][Full Text] [Related]
26. Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin.
Tabernero L; Chang CY; Ohringer SL; Lau WF; Iwanowicz EJ; Han WC; Wang TC; Seiler SM; Roberts DG; Sack JS
J Mol Biol; 1995 Feb; 246(1):14-20. PubMed ID: 7853394
[TBL] [Abstract][Full Text] [Related]
27. Nonpolar interactions of thrombin and its inhibitors at the fibrinogen recognition exosite: thermodynamic analysis.
Cheng Y; Slon-Usakiewicz JJ; Wang J; Purisima EO; Konishi Y
Biochemistry; 1996 Oct; 35(40):13021-9. PubMed ID: 8855937
[TBL] [Abstract][Full Text] [Related]
28. Structure of the non-covalent complex of prothrombin kringle 2 with PPACK-thrombin.
Arni RK; Padmanabhan K; Padmanabhan KP; Wu TP; Tulinsky A
Chem Phys Lipids; 1994 Jan; 67-68():59-66. PubMed ID: 8187245
[TBL] [Abstract][Full Text] [Related]
29. The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution.
Martin PD; Robertson W; Turk D; Huber R; Bode W; Edwards BF
J Biol Chem; 1992 Apr; 267(11):7911-20. PubMed ID: 1560020
[TBL] [Abstract][Full Text] [Related]
30. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
[TBL] [Abstract][Full Text] [Related]
31. The effects of exosite occupancy on the substrate specificity of thrombin.
Ng NM; Quinsey NS; Matthews AY; Kaiserman D; Wijeyewickrema LC; Bird PI; Thompson PE; Pike RN
Arch Biochem Biophys; 2009 Sep; 489(1-2):48-54. PubMed ID: 19638274
[TBL] [Abstract][Full Text] [Related]
32. Thrombomodulin Binding Selects the Catalytically Active Form of Thrombin.
Handley LD; Treuheit NA; Venkatesh VJ; Komives EA
Biochemistry; 2015 Nov; 54(43):6650-8. PubMed ID: 26468766
[TBL] [Abstract][Full Text] [Related]
33. Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms.
Priestle JP; Rahuel J; Rink H; Tones M; Grütter MG
Protein Sci; 1993 Oct; 2(10):1630-42. PubMed ID: 8251938
[TBL] [Abstract][Full Text] [Related]
34. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
[TBL] [Abstract][Full Text] [Related]
35. Expression of allosteric linkage between the sodium ion binding site and exosite I of thrombin during prothrombin activation.
Kroh HK; Tans G; Nicolaes GA; Rosing J; Bock PE
J Biol Chem; 2007 Jun; 282(22):16095-104. PubMed ID: 17430903
[TBL] [Abstract][Full Text] [Related]
36. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II.
Monteiro RQ; Rapôso JG; Wisner A; Guimarães JA; Bon C; Zingali RB
Biochem Biophys Res Commun; 1999 Sep; 262(3):819-22. PubMed ID: 10471408
[TBL] [Abstract][Full Text] [Related]
37. Refined structure of the hirudin-thrombin complex.
Rydel TJ; Tulinsky A; Bode W; Huber R
J Mol Biol; 1991 Sep; 221(2):583-601. PubMed ID: 1920434
[TBL] [Abstract][Full Text] [Related]
38. Structure of the Ser195Ala mutant of human alpha--thrombin complexed with fibrinopeptide A(7--16): evidence for residual catalytic activity.
Krishnan R; Sadler JE; Tulinsky A
Acta Crystallogr D Biol Crystallogr; 2000 Apr; 56(Pt 4):406-10. PubMed ID: 10739913
[TBL] [Abstract][Full Text] [Related]
39. The crystal structure of human alpha-thrombin complexed with LY178550, a nonpeptidyl, active site-directed inhibitor.
Chirgadze NY; Sall DJ; Klimkowski VJ; Clawson DK; Briggs SL; Hermann R; Smith GF; Gifford-Moore DS; Wery JP
Protein Sci; 1997 Jul; 6(7):1412-7. PubMed ID: 9232642
[TBL] [Abstract][Full Text] [Related]
40. The determination of protonation states in proteins.
Ahmed HU; Blakeley MP; Cianci M; Cruickshank DW; Hubbard JA; Helliwell JR
Acta Crystallogr D Biol Crystallogr; 2007 Aug; 63(Pt 8):906-22. PubMed ID: 17642517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]